Skip to main content
Clinical Trials/TCTR20220122001
TCTR20220122001CompletedPhase 2

The Effect of supplemental Oxygen on 6-minute Walk Test in Chronic Obstructive Pulmonary Disease (COPD) Patients

Isfahan University of Medical Sciences0 sites100 target enrollmentStarted: January 22, 2022Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
100

Study Overview

Brief Summary

supplemental oxygen used in the time of exercise testing or 6MWT has a considerable positive effect in cases with COPD.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 Years to 99 Years (—)
Sex
All

Inclusion Criteria

  • (I) definitive diagnosis of moderate to severe COPD, (II) weeks without exacerbations), (III) lack of acute coronary syndrome, (IV) FEV 1 /FVC ratio of less than 0.7, and 50 %< FEV<80% (stage 2) and 30 %< FEV<50% (stage 3), (V) a cigarettes smoking history of more than 10 pack-years, and (VI) ability to walk.

Exclusion Criteria

  • 1-Patients with complications during the test were excluded from the study.
  • 2- Patients who didn't have informed consent.
  • 3- patients with other serious health problems.

Investigators

Similar Trials